Leveraging Real-World Evidence for drug approval
The FDA approved it in 2016, but the question remains: Is real-world evidence a suitable substitute for randomized clinical trials? Knect365 interviews Dan Danielson, Senior Director of the Access Experience Team at Precision for Value, on the opportunities and challenges of real-world evidence.